Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

9
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
9
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

441
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
441
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

696
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
696
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

10
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
10

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Murine thrombus organization limits access to high platelet activation states while supporting platelet recruitment.

Blood vessels, thrombosis & hemostasis·2026
Same author

Get a GRIP: How cargo gets to platelet α-granules.

The Journal of cell biology·2026
Same author

Animal Models of Aortic Aneurysm and Dissection: A Comparative Guide for Mechanism, Therapeutic Testing, and Translational Readouts.

Biomedicines·2026
Same author

Platelet α-granule cargo packaging and endocytosis are important for normal mouse skin wound healing.

Blood advances·2026
Same author

Role of Rubicon in platelets: a promoter of thrombosis but not an autophagy repressor.

Blood advances·2025
Same author

Bacterial interactions with platelets: defining key themes.

Frontiers in immunology·2025
Same journal

Hexokinase controls platelet activation and hemostasis.

Platelets·2026
Same journal

Chemiluminescence resonance energy transfer-based method to investigate the platelet surface molecule in acute myocardial infarction.

Platelets·2026
Same journal

Nanobodies to GPVI as alternative reagents for platelet spreading.

Platelets·2026
Same journal

Neural network reveals platelet age from fluorescence microscopy images.

Platelets·2026
Same journal

Sixty years of research into ancestry differences in platelet function.

Platelets·2026
Same journal

Platelet-rich plasma concentrations regulate MSCs osteogenesis via MAPK/PI3K-AKT pathways to mitigate inflammatory bone loss.

Platelets·2026
See all related articles

Related Experiment Video

Updated: Oct 5, 2025

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

13.9K

Platelet-HIV: interactions and their implications.

Sidney W Whiteheart1,2

  • 1Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, KY, USA.

Platelets
|January 28, 2022
PubMed
Summary
This summary is machine-generated.

Platelets interact with HIV, influencing cardiovascular disease risk in patients on antiretroviral therapy (ART). Understanding these interactions is key to developing new platelet-directed HIV/AIDS therapies.

Keywords:
AIDSHIVendocytosisplateletsviremia

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.6K
Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.6K

Related Experiment Videos

Last Updated: Oct 5, 2025

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

13.9K
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.6K
Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.6K

Area of Science:

  • Virology
  • Immunology
  • Hematology

Background:

  • Platelet-virus interactions are not fully understood for all viral infections.
  • Human Immunodeficiency Virus (HIV) infection, managed with antiretroviral therapeutics (ART), is now a chronic condition associated with increased cardiovascular disease risk.
  • The specific mechanisms by which HIV affects platelets remain an area of active investigation.

Purpose of the Study:

  • To discuss open questions regarding platelet interactions with HIV.
  • To explore the fate of HIV virions bound to platelets.
  • To investigate the nature of virus-induced platelet activation in HIV infection.

Main Methods:

  • This is an opinion article, therefore no specific experimental methods were employed.
  • Discussion is based on existing literature and expert opinion.
  • Key questions are posed to guide future research.

Main Results:

  • The article does not present new experimental results.
  • It highlights knowledge gaps in understanding HIV-platelet interactions.
  • It suggests potential roles for platelets in HIV pathogenesis and spread.

Conclusions:

  • Further research is needed to elucidate the precise mechanisms of HIV-platelet interactions.
  • Understanding these interactions may reveal novel therapeutic targets.
  • Platelet-directed therapies could potentially benefit HIV/AIDS patients, particularly concerning cardiovascular complications.